Please assess the completion status of the following clinical trial:

Trial Title: Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Female age \> 18 years~2. Invasive breast cancer ≤ 5 cm, unifocal bifocal or multifocal~3. Diagnosis confirmed by biopsy~4. Breast cancer extended in situ~5. First surgical treatment~Exclusion Criteria:~1. Neoadjuvant chemotherapy or hormone therapy.~2. Multicentric tumor~3. Pregnant patient~4. Ongoing participation in another clinical trial with an investigational drug

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Infracyanine (Type: EXPERIMENTAL): In the beginning of the intervention, a periareolar injection of the Infracyanine will be carried out (Infracyanine®, 2ml to 2.5mg/ml whether 3.2nM).

Based on this trial design, predict the completion outcome and termination type (if applicable).